Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Jan 19;14(3):497. doi: 10.3390/cancers14030497

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2022 by the authors.

Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).

PMC Copyright notice

CAR targets in AML and CAR therapies currently in clinical trials. CAR = chimeric antigen receptor; AML = acute myeloid leukemia; CD = cluster of differentiation; CLL-1 = C-type lectin-like molecule-1; FLT3 = FMS related receptor tyrosine kinase 3; FRb = folate receptor b; HSC = hematopoietic stem cell; GM-CSF = granulocyte-macrophage colony-stimulated factor; ILT3 = Ig-like transcript 3; LSC = leukemic stem cell; NKG2D = natural killer group 2 member D; Siglec-6 = sialic acid binding Ig-like lectin 6.